All In MedTech

Device Trial Radar · NCT02112877

VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction

VIRTUS Safety and Efficacy of the Veniti Vici™ Venous Stent System (Veniti, Inc.) When Used to Treat Clinically Significant Chronic Non-malignant Obstruction of the Iliofemoral Venous Segment

Last checked: Nov 20, 2026Latest source record: Apr 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

200

Actual

Start

Jun 26, 2014

Primary completion

Dec 5, 2017

Study completion Dec 18, 2020

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Apr 14, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-center, single arm, non-randomized study to define safety and efficacy of the Veniti Vici™ Venous Stent System in relation to pre-defined Objective Performance goals. A maximum of 200 patients at up to 45 centers worldwide will be enrolled. Thirty (30) feasibility patients will be enrolled at approximately 7-10 centers and 170 pivotal patients will be enrolled at approximately 45 centers worldwide. The follow-up period is 36 months.

Conditions

  • Chronic Venous Disorder
  • Venous Outflow Obstruction
  • Symptomatic Venous Outflow Obstruction of Iliofemoral Vein

Interventions

  • Veniti Vici™ Venous Stent SystemDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Major Adverse Events (MAE)Time frame: 30 days
  2. Percentage of Participants That Demonstrated Primary PatencyTime frame: 12 months post-intervention

Locations

24 sites in 7 countries. Site status is shown where the registry gives one.

  • Abrazo Arizona Heart Hospital

    Phoenix, Arizona

  • Healthfinity PLCC

    Scottsdale, Arizona

  • Arkansas Site Management Services, LLC

    Little Rock, Arkansas

21 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.